Han Tong

Doudou Zhou, Han Tong, Linshanshan Wang et al.

The adoption of EHRs has expanded opportunities to leverage data-driven algorithms in clinical care and research. A major bottleneck in effectively conducting multi-institutional EHR studies is the data heterogeneity across systems with numerous codes that either do not exist or represent different clinical concepts across institutions. The need for data privacy further limits the feasibility of including multi-institutional patient-level data required to study similarities and differences across patient subgroups. To address these challenges, we developed the GAME algorithm. Tested and validated across 7 institutions and 2 languages, GAME integrates data in several levels: (1) at the institutional level with knowledge graphs to establish relationships between codes and existing knowledge sources, providing the medical context for standard codes and their relationship to each other; (2) between institutions, leveraging language models to determine the relationships between institution-specific codes with established standard codes; and (3) quantifying the strength of the relationships between codes using a graph attention network. Jointly trained embeddings are created using transfer and federated learning to preserve data privacy. In this study, we demonstrate the applicability of GAME in selecting relevant features as inputs for AI-driven algorithms in a range of conditions, e.g., heart failure, rheumatoid arthritis. We then highlight the application of GAME harmonized multi-institutional EHR data in a study of Alzheimer's disease outcomes and suicide risk among patients with mental health disorders, without sharing patient-level data outside individual institutions.

Han Tong, Shubhangi Ghosh, Haolin Zou et al.

Data attribution, tracing a model's prediction back to specific training data, is an important tool for interpreting sophisticated AI models. The widely used TRAK algorithm addresses this challenge by first approximating the underlying model with a kernel machine and then leveraging techniques developed for approximating the leave-one-out (ALO) risk. Despite its strong empirical performance, the theoretical conditions under which the TRAK approximations are accurate as well as the regimes in which they break down remain largely unexplored. In this paper, we provide a theoretical analysis of the TRAK algorithm, characterizing its performance and quantifying the errors introduced by the approximations on which the method relies. We show that although the approximations incur significant errors, TRAK's estimated influence remains highly correlated with the original influence and therefore largely preserves the relative ranking of data points. We corroborate our theoretical results through extensive simulations and empirical studies.

Kimberly F. Greco, Zongxin Yang, Mengyan Li et al.

Rare diseases affect an estimated 300-400 million people worldwide, yet individual conditions remain underdiagnosed and poorly characterized due to their low prevalence and limited clinician familiarity. Computational phenotyping offers a scalable approach to improving rare disease detection, but algorithm development is hindered by the scarcity of high-quality labeled data for training. Expert-labeled datasets from chart reviews and registries are clinically accurate but limited in scope and availability, whereas labels derived from electronic health records (EHRs) provide broader coverage but are often noisy or incomplete. To address these challenges, we propose WEST (WEakly Supervised Transformer for rare disease phenotyping and subphenotyping from EHRs), a framework that combines routinely collected EHR data with a limited set of expert-validated cases and controls to enable large-scale phenotyping. At its core, WEST employs a weakly supervised transformer model trained on extensive probabilistic silver-standard labels - derived from both structured and unstructured EHR features - that are iteratively refined during training to improve model calibration. We evaluate WEST on two rare pulmonary diseases using EHR data from Boston Children's Hospital and show that it outperforms existing methods in phenotype classification, identification of clinically meaningful subphenotypes, and prediction of disease progression. By reducing reliance on manual annotation, WEST enables data-efficient rare disease phenotyping that improves cohort definition, supports earlier and more accurate diagnosis, and accelerates data-driven discovery for the rare disease community.